CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K/ as therapy for T cell acute lymphoblastic leukemia (T-ALL).
For research use only. We do not sell to patients.
| Name | CAL-130 |
|---|---|
| Iupac Chemical Name | CAL-130 |
| Synonyms | CAL130; CAL 130 |
| Molecular Formula | C23H22N8O |
| Molecular Weight | 426.47 |
| InChiKey | |
| InChi | |
| CAS Number | 1431697-74-3 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |